Verapamil is a phenylalkylamine calcium channel blocker used in the treatment of high blood pressure, heart arrhythmias, and angina, and was the first calcium channel antagonist to be introduced into therapy in the early 1960s. It is a member of the non-dihydropyridine class of calcium channel blockers, which includes drugs like diltiazem and flunarizine, bu...
Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal's) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter....
AP-HP Hôpital la Timone, Marseille, France
CHU de Nice, NICE Cedex 1, Chun, France
Faculty of medicine Assiut university, Assiut, Egypt
Nicolaus Copernicus University, Bydgoszcz, Poland
Ain Shams university, Cairo, Egypt
Richmond Pharmacology Ltd, London, United Kingdom
Northwestern University, Chicago, Illinois, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Loma Linda University Health, Loma Linda, California, United States
Crozer Keystone Health System, Upland, Pennsylvania, United States
CTC North GmbH & Co. KG, Hamburg, Hamburg, Germany
Covance Clinical Research Unit, Daytona Beach, Florida, United States
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.